Who owns Dafalgan?
Dafalgan is owned by Taisho Pharmaceutical (Japan).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Taisho Pharmaceutical: History, Taisho Pharmaceutical Co., Ltd. Last checked .
Key facts
- Current owner
- Taisho Pharmaceutical Holdings Co., Ltd. reported
- Owner HQ
- 🇯🇵 Japan, Tokyo
- Origin
- 🇫🇷 France
- Category
- Consumer health › Over-the-counter medicine › Pain relief
- Last verified
- · 1 sources
About Dafalgan
Paracetamol-based pain reliever indicated for mild to moderate pain such as fever and muscle pain, listed by Taisho as one of its two European brands, with Efferalgan. It belongs to UPSA, the French over-the-counter company that became a wholly owned Taisho subsidiary in 2019 and is based in Rueil-Malmaison.
Ownership timeline of Dafalgan
- Current owner Taisho Pharmaceutical [1] reported
Where Dafalgan sits in Taisho Pharmaceutical
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Taisho Pharmaceutical ownership tree →
See the full Taisho Pharmaceutical brand portfolio (7) →
Other brands owned by Taisho Pharmaceutical
Taisho Pharmaceutical controls 7 brands on Brandtree, 6 of them in consumer health.
Also in consumer health
- Biofermin
- Efferalgan
- Hapacol
- Naron (1960)
- Pabron (1927)
Other brands in pain relief, and who owns them
The 34 brands in pain relief on Brandtree belong to 19 owners. The largest is Haleon, with 3; Taisho Pharmaceutical has 3.
| Brand | Owner | Owner based in |
|---|---|---|
| Advil | Haleon | 🇬🇧 United Kingdom |
| Air Salonpas | Hisamitsu Pharmaceutical | 🇯🇵 Japan |
| Motrin | Kenvue | 🇺🇸 United States |
| Mentho Plus | Emami | 🇮🇳 India |
| Bufferin (United States) | Genomma Lab | 🇲🇽 Mexico |
| Doril | Hypera | 🇧🇷 Brazil |
| Daleron | Krka | 🇸🇮 Slovenia |
| Kunyit Asam Sido Muncul | Sido Muncul | 🇮🇩 Indonesia |
About the owner: Taisho Pharmaceutical
Taisho Pharmaceutical is a privately held company headquartered in Tokyo, Japan, founded in 1912. Brandtree records 7 brands under its control.
Japanese pharmaceutical and over-the-counter health company, founded in 1912 and based in Toshima-ku, Tokyo. Its shares were delisted from the stock exchange on 9 April 2024, so it is now unlisted. Outside Japan it bought Bristol-Myers Squibb's Asian OTC trademarks in 2009 and took control of Vietnam's Duoc Hau Giang (DHG) and France's UPSA in 2019; Taisho also sells some brands in Japan under licence from other owners (for example Vicks and Claritin), which are not listed here.
Taisho Pharmaceutical: full profile, brands and acquisition history →
🇫🇷 Dafalgan and other French brands
Brandtree records a controlling owner for 318 brands that began in France. 99 of them (31%) are now controlled by a company headquartered in another country, Dafalgan among them.
Frequently asked questions
Who is the parent company of Dafalgan?
The parent company of Dafalgan is Taisho Pharmaceutical, a privately held company headquartered in Japan.
Is Dafalgan French or Japanese?
Dafalgan originated in France, but it is owned today by Taisho Pharmaceutical, which is headquartered in Japan. So Dafalgan is a French-origin brand under Japanese ownership.
Is Dafalgan still owned by Taisho Pharmaceutical?
Yes. As of 4 October 2026, Dafalgan is still owned by Taisho Pharmaceutical. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Taisho Pharmaceutical: History — Taisho Pharmaceutical Co., Ltd., Official document; retrieved 4 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.